论文部分内容阅读
目的:探讨经直肠超声造影技术在前列腺癌的诊断及靶向引导前列腺癌的穿刺活检中的临床应用价值。方法:对72例血清前列腺特异抗原(PSA)升高(≥4.00ng/ml)的患者进行经直肠前列腺穿刺。结果:72例患者共穿刺820针,经穿刺病理诊断为前列腺癌的为29例。结论:CE-TRUS较TRUS能检出更多的前列腺癌病例数,其引导的靶向穿刺较系统穿刺具有更好的单针阳性率,但由于在病人检出率上的差异,靶向穿刺仍无法取代系统穿刺。
Objective: To investigate the clinical value of transrectal ultrasound in the diagnosis of prostate cancer and the biopsy of prostate cancer. Methods: Transrectal prostate puncture was performed in 72 patients with elevated serum PSA (≥4.00 ng / ml). Results: A total of 820 patients were punctured in 72 patients, and 29 patients were diagnosed as prostate cancer by puncture pathology. CONCLUSIONS: CE-TRUS can detect more cases of prostate cancer than TRUS, and the guided targeted punctures have better single-needle positive rates than systemic punctures. However, due to the difference in the detection rate of the patients, the targeted punctures Still can not replace the system puncture.